Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dentsply SironaXRAY -8.08%55 EV-to-OCF is 14.11 as of Aug. 09, 2026, which is 32% below its 10-year median of 20.76. GuruFocus rates XRAY with a GF Score™ of 55/100 and a GF Value™ of $17.55 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Dentsply Sirona ranks worse than 64.13% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Dentsply Sirona's Enterprise Value is $4,502 Mil.
Dentsply Sirona's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $319 Mil. Therefore, Dentsply Sirona's EV-to-OCF for today is 14.11.
The historical rank and industry rank for Dentsply Sirona's EV-to-OCF or its related term are showing as below:
XRAY'
s EV-to-OCF Range Over the Past 10 Years
Min: 10.33 Med: 20.76 Max: 33.43
Current: 14.11
During the past 13 years, the highest EV-to-OCF of Dentsply Sirona was 33.43. The lowest was 10.33. And the median was 20.76.
XRAY's EV-to-OCF is ranked worse than 64.13% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.82
vs XRAY: 14.11
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dentsply Sirona's PE Ratio (TTM) for today is calculated as:
Dentsply Sirona's share price for today is $12.12.
Dentsply Sirona's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.750.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Dentsply Sirona EV-to-OCF Related Terms
Dentsply Sirona EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Dentsply Sirona's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dentsply Sirona EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's EV-to-OCF falls into.
Dentsply Sirona's current Enterprise Value is $4,502 Mil.
Dentsply Sirona's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $319 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona (XRAY) has a EV-to-OCF of 14.11 as of Aug. 09, 2026. This is 32% below median its historical median of 20.76. Over the past decade, Dentsply Sirona's EV-to-OCF has ranged from 10.33 to 33.43. According to the industry distribution chart, Dentsply Sirona ranks #547 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 64.1%.
Is Dentsply Sirona's EV-to-OCF too high?
Dentsply Sirona's current EV-to-OCF of 14.11 is 32% below median its 10-year median of 20.76. Over the past 10 years, this metric has ranged from a low of 10.33 to a high of 33.43. The Medical Devices & Instruments industry median EV-to-OCF is 7.82. Dentsply Sirona's value of 14.11 is 80.4% above this industry median. Based on the distribution chart, Dentsply Sirona ranks #547 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Dentsply Sirona has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's EV-to-OCF compare to LMAT and WRBY?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #547 out of 853 companies for EV-to-OCF. This places Dentsply Sirona in the lower half of its industry. The industry median EV-to-OCF is 7.82. Dentsply Sirona's value of 14.11 is 80.4% above this benchmark. Historically, Dentsply Sirona's own EV-to-OCF has ranged from 10.33 to 33.43 over the past decade. While the company's 10-year median is 20.76 vs. the industry median of 7.82, Dentsply Sirona has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.82, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dentsply Sirona's current EV-to-OCF of 14.11 is 80.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dentsply Sirona's current EV-to-OCF is 14.11, which is 32% below median its own 10-year median of 20.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $17.55, compared to a current price of $12.12 — trading 30.9% below its estimated fair value. The current EV-to-OCF is 14.11, which is 32% below median its 10-year median of 20.76 and 80.4% above the Medical Devices & Instruments industry median of 7.82. Dentsply Sirona's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current EV-to-OCF is 14.11 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $12.12 is trading 30.9% below its estimated GF Value™ of $17.55.
GuruFocus considers Dentsply Sirona to be Possible Value Trap.
Key valuation signals for XRAY:
EV-to-OCF: 14.11 (32% below median its 10-year median of 20.76)
GF Value™: $17.55 vs. price of $12.12 (30.9% below fair value)
Industry Position: 80.4% above the Medical Devices & Instruments median (#547 of 853)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
55GF Score
Get the complete analysis for XRAY
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
